Vaxart (VXRT)

• Market cap: $141M
• 1 day: 2.70%
• 5 days: 5.00%
• 1 month: 1.94%
• 3 months: -25.74%
• 6 months: -13.81%
• Year to date: 1.74%
• 1 year: 2.75%
• 5 years: 117.02%
• 10 years: -96.54%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

About: Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Employees: 109

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

64% more call options, than puts

Call options by funds: $301K | Put options by funds: $183K

18% more capital invested

Capital invested by funds: $27.1M [Q2] → $31.9M (+$4.79M) [Q3]

1% more funds holding

Funds holding: 98 [Q2] → 99 (+1) [Q3]

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

1.34% less ownership

Funds ownership: 17.85% [Q2] → 16.52% (-1.34%) [Q3]

48% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 27